Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US8816242098

SecurityTEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionBessemer Group Inc
Latest Disclosed Ownership4,350,483 shares
Latest Disclosed Value $ 131,036
Bessemer Group Inc reports 1.64% increase in ownership of TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On May 6, 2026 - Bessemer Group Inc filed a 13F-HR form disclosing ownership of 4,350,483 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (US:TEVA) valued at $131,036,548 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 4,280,425 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). This represents a change in shares of 1.64% during the quarter. The current value of the position is $142,826,357 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F TEVA PHARM INDS LTD ADR SA 881624209 4,350,483 70,058 1.64 131 -1.50 0.2060
2026-02-05 2025-12-31 13F TEVA PHARM INDS LTD ADR SA 881624209 4,280,425 4,279,928 861,152.52 134 0.2051
2025-11-05 2025-09-30 13F TEVA PHARM INDS LTD ADR SA 881624209 497 146 41.60 0 0.0000
2025-08-01 2025-06-30 13F TEVA PHARM INDS LTD ADR SA 881624209 351 0 0.00 0 0.0000
2025-04-23 2025-03-31 13F TEVA PHARM INDS LTD ADR SA 881624209 351 84 31.46 0 0.0000
2025-02-13 2024-12-31 13F TEVA PHARM INDS LTD ADR SA 881624209 267 0 0.00 0 0.0000
2024-11-12 2024-09-30 13F TEVA PHARM INDS LTD ADR SA 881624209 267 87 48.33 0 0.0000
2024-08-13 2024-06-30 13F TEVA PHARM INDS LTD ADR SA 881624209 180 0 0.00 0 0.0000
2024-08-13 2024-03-31 13F/A-1 TEVA PHARM INDS LTD ADR SA 881624209 180 180 0 0.0000
2024-05-13 2024-03-31 13F TEVA PHARM INDS LTD ADR SA 881624209 180 180 0 0.0000
2023-05-10 2023-03-31 13F TEVA PHARM INDS LTD ADR SA 881624209 0 -2,670 -100.00 0 0.0000
2023-02-13 2022-12-31 13F TEVA PHARM INDS LTD ADR SA 881624209 2,670 2,500 1,470.59 0 -100.00 0.0001
2022-11-09 2022-09-30 13F TEVA PHARM INDS LTD ADR SA 881624209 170 0 0.00 1 0.00 0.0000
2022-08-10 2022-06-30 13F TEVA PHARM INDS LTD ADR SA 881624209 170 -803 -82.53 1 -88.89 0.0000
2022-05-12 2022-03-31 13F TEVA PHARM INDS LTD ADR SA 881624209 973 -1,906 -66.20 9 -60.87 0.0000
2022-01-27 2021-12-31 13F TEVA PHARM INDS LTD ADR SA 881624209 2,879 1,520 111.85 23 76.92 0.0000
2021-11-12 2021-09-30 13F TEVA PHARM INDS LTD ADR SA 881624209 1,359 137 11.21 13 8.33 0.0000
2021-08-06 2021-06-30 13F TEVA PHARM INDS LTD ADR SA 881624209 1,222 -3,070 -71.53 12 -76.00 0.0000
2021-05-13 2021-03-31 13F TEVA PHARM INDS LTD ADR SA 881624209 4,292 838 24.26 50 51.52 0.0001
2021-02-09 2020-12-31 13F TEVA PHARM INDS LTD ADR SA 881624209 3,454 0 0.00 33 6.45 0.0001
2020-11-12 2020-09-30 13F TEVA PHARM INDS LTD ADR SA 881624209 3,454 0 0.00 31 -27.91 0.0001
2020-08-05 2020-06-30 13F TEVA PHARM INDS LTD ADR SA 881624209 3,454 580 20.18 43 65.38 0.0001
2020-04-30 2020-03-31 13F TEVA PHARM INDS LTD ADR SA 881624209 2,874 50 1.77 26 -7.14 0.0001
2020-02-04 2019-12-31 13F TEVA PHARM INDS LTD ADR SA 881624209 2,824 -50 -1.74 28 40.00 0.0001
2019-11-07 2019-09-30 13F TEVA PHARM INDS LTD ADR SA 881624209 2,874 11 0.38 20 -23.08 0.0001
2019-07-19 2019-06-30 13F TEVA PHARM INDS LTD ADR SA 881624209 2,863 0 0.00 26 -42.22 0.0001
2019-05-13 2019-03-31 13F TEVA PHARM INDS LTD ADR SA 881624209 2,863 -249 -8.00 45 -6.25 0.0002
2019-05-21 2018-12-31 13F/A-1 TEVA PHARM INDS LTD ADR SA 881624209 3,112 141 4.75 48 -25.00 0.0002
2019-02-12 2018-12-31 13F TEVA PHARM INDS LTD ADR SA 881624209 3,112 141 48 0.0002
2018-11-06 2018-09-30 13F TEVA PHARM INDS LTD ADR SA 881624209 2,971 64 2.20 64 -9.86 0.0002
2018-07-25 2018-06-30 13F TEVA PHARM INDS LTD ADR SA 881624209 2,907 2,703 1,325.00 71 1,675.00 0.0003
2018-05-10 2018-03-31 13F TEVA PHARM INDS LTD ADR SA 881624209 204 0 0.00 4 0.00 0.0000
2018-01-30 2017-12-31 13F TEVA PHARM INDS LTD ADR SA 881624209 204 -412 -66.88 4 -63.64 0.0000
2017-11-03 2017-09-30 13F TEVA PHARM INDS LTD ADR SA 881624209 616 0 0.00 11 -45.00 0.0000
2017-07-27 2017-06-30 13F TEVA PHARM INDS LTD ADR SA 881624209 616 -247 -28.62 20 -28.57 0.0001
2017-05-12 2017-03-31 13F TEVA PHARM INDS LTD ADR SA 881624209 863 -1,913 -68.91 28 -72.28 0.0001
2017-02-07 2016-12-31 13F TEVA PHARM INDS LTD ADR SA 881624209 2,776 -27,915 -90.96 101 -92.85 0.0005
2016-11-10 2016-09-30 13F TEVA PHARM INDS LTD ADR SA 881624209 30,691 -18,650 -37.80 1,412 -43.04 0.0071
2016-08-11 2016-06-30 13F TEVA PHARM INDS LTD ADR SA 881624209 49,341 -1,222 -2.42 2,479 -8.39 0.0136
2016-05-11 2016-03-31 13F TEVA PHARM INDS LTD ADR SA 881624209 50,563 -1,021 -1.98 2,706 -20.06 0.0153
2016-02-12 2015-12-31 13F TEVA PHARM INDS LTD ADR SA 881624209 51,584 19,201 59.29 3,385 85.07 0.0189
2015-11-16 2015-09-30 13F TEVA PHARM INDS LTD ADR SA 881624209 32,383 19 0.06 1,829 -4.39 0.0105
2015-08-14 2015-06-30 13F TEVA PHARM INDS LTD ADR SA 881624209 32,364 30,048 1,297.41 1,913 1,228.47 0.0100
2015-06-18 2015-03-31 13F/A-1 TEVA PHARM INDS LTD ADR SA 881624209 2,316 5 0.22 144 8.27 0.0007
2015-05-14 2015-03-31 13F TEVA PHARM INDS LTD ADR SA 881624209 2,316 144
2015-02-17 2014-12-31 13F TEVA PHARM INDS LTD ADR SA 881624209 2,311 1,986 611.08 133 682.35 0.0007
2014-12-11 2014-09-30 13F/A-1 TEVA PHARM INDS LTD ADR SA 881624209 325 -2,128 -86.75 17 -86.82 0.0001
2014-11-13 2014-09-30 13F TEVA PHARM INDS LTD ADR SA 881624209 325 -2,128 17 0.0001
2014-08-13 2014-06-30 13F TEVA PHARM INDS LTD ADR SA 881624209 2,453 1,198 95.46 129 92.54 0.0008
2014-05-14 2014-03-31 13F TEVA PHARM INDS LTD ADR SA 881624209 1,255 -200,449 -99.38 67 -99.17 0.0005
2014-02-18 2013-12-31 13F TEVA PHARM INDS LTD ADR SA 881624209 201,704 -2,512,446 -92.57 8,084 -92.12 0.0579
2013-11-08 2013-09-30 13F TEVA PHARM INDS LTD ADR SA 881624209 2,714,150 54,949 2.07 102,529 -1.64 0.8318
2013-08-14 2013-06-30 13F TEVA PHARM INDS LTD ADR SA 881624209 2,659,201 2,659,201 104,240 0.9347
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.